August 22, 2023
Move over, ChatGPT: These artificial intelligence-powered technologies and innovations being developed and implemented at UC San Diego could lead to the next developments in the “AI revolution.”
May 30, 2018
The race is on between new antibiotics and drug-resistant bacteria—and scientists are challenged to keep up. By 2050, according to a Wellcome Trust study, deaths from deadly infections will be more common than cancer deaths. Scientists report that currently antimicrobial resistance causes 23,000 deaths annually in the U.S.; 700,000 deaths…
November 19, 2012
For work toward a safer approach to treating cancer, electrical engineering Ph.D. student Inanc Ortac from the University of California, San Diego has won first prize in the graduate student category at the 2012 Collegiate Inventors Competition.
December 5, 2017
A new small-molecule drug can restore brain function and memory in a mouse model of Alzheimer’s disease. The molecule, called anle138b, works by stopping toxic ion flow in the brain that is known to trigger nerve cell death. Scientists envision that this drug could be used to treat Alzheimer’s and…
October 4, 2012
…a molecular approach to delivering drugs that could change the pharmaceutical industry worldwide. The W.M. Keck Foundation of Los Angeles supports “high risk/high reward” pioneering discoveries in groundbreaking studies that enable researchers to translate their innovative ideas into real world impact. Steve Dowdy, a professor in the department of cellular…
August 26, 2016
Researchers at University of California San Diego School of Medicine and Moores Cancer Center have identified RNA-based biomarkers that distinguish between normal, aging hematopoietic stem cells and leukemia stem cells associated with secondary acute myeloid leukemia (sAML), a particularly problematic disease that typically afflicts older patients who have often already…
December 15, 2015
Shu Chien, Distinguished Professor of Bioengineering and Medicine, and Michael Sailor, Distinguished Professor of Chemistry and Biochemistry, were among 168 new fellows announced by the academy today.
August 10, 2017
…track RNA in live cells in a method called RNA-targeting Cas9. In a study published August 10 in Cell, the team took RCas9 a step further: they corrected molecular mistakes that lead to microsatellite repeat expansion diseases, which include a type of ALS and Huntington’s disease.
August 2, 2017
Ultrasound brain surgery has enormous potential for the treatment of neurological diseases and cancers, but getting therapeutic sound waves through the skull and into the brain is no easy task. To address this problem, an international team of researchers has developed a window-like cranial implant through which doctors can deliver…
May 9, 2013
DARPA, the U.S. Defense Advanced Research Projects Agency, has awarded $6 million to a team of researchers to develop nanotechnology therapies for the treatment of traumatic brain injury and associated infections.
